About Nicole Vitullo
Nicole Vitullo is a director and 10% owner at Esperion Therapeutics.
Form D filings name Nicole Vitullo as a director at Allay Therapeutics and Abrexa Pharmaceuticals.
Nicole Vitullo reports to the SEC as a director or major shareholder of 33 public companies, including Marinus Pharmaceuticals (MRNS), Achillion Pharmaceuticals (ACHN) and Vyome (HIND).
Nicole Vitullo first appears on SEC filings in 2006.
Experience
This experience comes from SEC filings. The years are when the filings name Nicole Vitullo in the role, so the role may have started earlier or lasted longer.
EI
Esperion Therapeutics, Inc.
Director and 10% owner
2013 – 2025 · Public company (ESPR)
MI
Marinus Pharmaceuticals, Inc.
Director and 10% owner
2014 – 2022 · Public company (MRNS)
AI
Achillion Pharmaceuticals Inc.
Director and 10% owner
2010 – 2020 · Public company (ACHN)
VI
Vyome Holdings, Inc
10% owner
2016 – 2019 · Public company (HIND)
AI
Adynxx, Inc.
10% owner
2019 · Public company (ADYX)
BI
Bionano Genomics, Inc.
10% owner
2018 · Public company (BNGO)
DI
Dicerna Pharmaceuticals Inc
10% owner
2014 – 2017 · Public company (DRNA)
OI
Ocera Therapeutics, Inc.
10% owner
2013 – 2017 · Public company (OCRX)
TI
Tobira Therapeutics, Inc.
10% owner
2013 – 2016 · Public company (TBRA)
CI
CoLucid Pharmaceuticals, Inc.
10% owner
2015 – 2016 · Public company (CLCD)
CI
Celator Pharmaceuticals Inc
Director and 10% owner
2013 – 2016 · Public company
EI
Evoke Pharma Inc
10% owner
2013 – 2016 · Public company (EVOK)
SI
Syndax Pharmaceuticals Inc
10% owner
2016 · Public company (SNDX)
GC
Glaukos Corp.
10% owner
2015 · Public company (GKOS)
AI
aTYR PHARMA INC
10% owner
2015 · Public company (ATYR)
EI
Evofem Biosciences, Inc.
10% owner
2014 · Public company (EVFM)
DI
Durata Therapeutics, Inc.
Director and 10% owner
2012 – 2014 · Public company (DRTX)
AI
Atara Biotherapeutics, Inc.
10% owner
2014 · Public company (ATRA)
VI
Veracyte, Inc.
10% owner
2013 – 2014 · Public company (VCYT)
OI
Otonomy, Inc.
10% owner
2014 · Public company (OTIC)
AI
Aldeyra Therapeutics, Inc.
10% owner
2014 · Public company (ALDX)
CI
Cadence Pharmaceuticals Inc.
10% owner
2006 – 2014 · Public company (CADX)
AI
Achaogen, Inc.
10% owner
2014 · Public company (AKAO)
AI
Alimera Sciences Inc.
10% owner
2010 – 2014 · Public company (ALIM)
TI
Tandem Diabetes Care Inc.
10% owner
2013 · Public company (TNDM)
CI
Clovis Oncology, Inc.
10% owner
2011 – 2013 · Public company (CLVS)
OI
Orexigen Therapeutics, Inc.
10% owner
2007 – 2011 · Public company (OREXQ)
ZI
Zogenix, Inc.
10% owner
2010 – 2011 · Public company (ZGNX)
VC
Volcano Corp
10% owner
2007 – 2008 · Public company (VOLC)
PI
Pernix Sleep, Inc.
10% owner
2006 · Public company (SOMX)
VI
Vanda Pharmaceuticals Inc.
10% owner
2006 · Public company (VNDA)
PI
Paratek Pharmaceuticals, Inc.
10% owner
2006 · Public company (PRTK)
NI
Northstar Neuroscience, Inc.
10% owner
2006 · Public company (NSTR)
Key Colleagues at Startups
The people Nicole Vitullo works with at each company, as listed on that company's latest Form D.
Allay Therapeutics, Inc. · Form D, Feb 10, 2025
LR
Leighton Read
Director
MD
Mark Deem
Director
MC
Michael Carusi
Director
TL
Tiffany Le
Director
AG
Adam Gridley
Chief Executive Officer and director
PM
Paul McCreadie
Director
JL
J.c. Lopez
Director
AT
Anselm Tan
Director
KH
Kristen Howells
Executive officer
Abrexa Pharmaceuticals, Inc. · Form D, Sep 6, 2011
ED
Eckard Weber, M.D.
President and Chief Executive Officer, director
LR
Lynne Rollins
Executive officer